Latest filing published 14 May 2009 for Arena Pharmaceuticals INC, €6,697.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
James Laforce: trading record in brief
James Laforce is a declared insider of Arena Pharmaceuticals Inc, with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 13 May 2008 and the latest from 14 May 2009.
Purchases make up the whole of the open-market record (3 purchases, €41k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2009 alone, the filings show 2 purchases and no sales.
Half of the purchases are above €6,697 and half below.
Most recently, on 14 May 2009, the filings show an open-market purchase worth €6,697 in Arena Pharmaceuticals Inc. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to James Laforce
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,300 shares@ US$2.74Common StockSEC:0001075514-09-000002:0Canonical exit: 12 Aug 2009 (T+90)
- 200 shares@ US$2.74Common StockSEC:0001075514-09-000002:1Canonical exit: 12 Aug 2009 (T+90)
2 of 2 declarations
